XOMA Royalty (XOMA) Cash from Investing Activities (2010 - 2026)

XOMA Royalty (XOMA) reported Cash from Investing Activities of $6.6 million for Q1 2026, up 197.89% on a YoY basis from $2.2 million in Q1 2025, and down 66.13% sequentially from $19.3 million in Q4 2025.

XOMA Royalty (XOMA) Cash from Investing Activities (2010 - 2026) Analysis & Trends

XOMA Royalty (XOMA) has 16 years of Cash from Investing Activities data on file, last reported at $6.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Investing Activities rose 197.89% year-over-year to $6.6 million; the trailing twelve-month figure through Mar 2026 stood at -$775000.0 (up 97.2% YoY), and the FY2025 full-year result was $50.9 million, up 280.07% from the prior year.
  • Cash from Investing Activities fell to $6.6 million in Q1 2026, from $19.3 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $19.3 million in Q4 2025 to a low of -$36.4 million in Q4 2024.
  • A 5-year average of -$3.3 million and a median of -$4.5 million in 2023 frame the typical range for Cash from Investing Activities.
  • Across the five-year window, Cash from Investing Activities jumped 21030.77% in 2023 and tumbled 761.06% in 2024, its largest moves.
  • Tracing XOMA's Cash from Investing Activities over 5 years: stood at -$15.2 million in 2022, then surged by 136.14% to $5.5 million in 2023, then plunged by 761.06% to -$36.4 million in 2024, then jumped by 153.11% to $19.3 million in 2025, then plunged by 66.13% to $6.6 million in 2026.
  • Business Quant data shows XOMA's Cash from Investing Activities at $6.6 million in Q1 2026, $19.3 million in Q4 2025, and -$20.0 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -45.51 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 172.62 Mn
10 XOMA Royalty 478.42 Mn 412.34 Mn - 6.55 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.55 Mn
Mar 31, 2026 6.55 Mn
Dec 31, 2025 19.35 Mn
Dec 31, 2025 19.35 Mn
Jun 30, 2025 -19.98 Mn
Jun 30, 2025 -19.98 Mn
Mar 31, 2025 -6.69 Mn
Mar 31, 2025 -6.69 Mn
Dec 31, 2024 -36.43 Mn
Dec 31, 2024 -36.43 Mn
Sep 30, 2024 9.52 Mn
Sep 30, 2024 9.52 Mn
Jun 30, 2024 5.90 Mn
Jun 30, 2024 5.90 Mn
Mar 31, 2024 -7.25 Mn
Mar 31, 2024 -7.25 Mn
Dec 31, 2023 5.51 Mn
Dec 31, 2023 5.51 Mn
Sep 30, 2023 5.49 Mn
Sep 30, 2023 5.49 Mn